IGFBP3 and head and neck squamous cell carcinoma: Several studies have confirmed that IGFBP3 suppresses the invasiveness of endometrial cancer (EC) cells [13], metastasis in prostate cancer [14], and angiogenesis in head and neck squamous cell carcinoma (HNSCC) [15].